These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 19483645)

  • 1. Cryopreservation of monocytes is superior to cryopreservation of immature or semi-mature dendritic cells for dendritic cell-based immunotherapy.
    Hayden H; Friedl J; Dettke M; Sachet M; Hassler M; Dubsky P; Bachleitner-Hofmann T; Gnant M; Stift A
    J Immunother; 2009; 32(6):638-54. PubMed ID: 19483645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of DC-based vaccine for therapy of B-CLL patients. Comparison of two methods for enriching monocytic precursors.
    Kokhaei P; Adamson L; Palma M; Osterborg A; Pisa P; Choudhury A; Mellstedt H
    Cytotherapy; 2006; 8(4):318-26. PubMed ID: 16923607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cryopreservation of monocytes or differentiated immature DCs leads to an altered cytokine response to TLR agonists and microbial stimulation.
    Meijerink M; Ulluwishewa D; Anderson RC; Wells JM
    J Immunol Methods; 2011 Oct; 373(1-2):136-42. PubMed ID: 21878338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Large-scale immunomagnetic selection of CD14+ monocytes to generate dendritic cells for cancer immunotherapy: a phase I study.
    Babatz J; Röllig C; Oelschlägel U; Zhao S; Ehninger G; Schmitz M; Bornhäuser M
    J Hematother Stem Cell Res; 2003 Oct; 12(5):515-23. PubMed ID: 14594508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental production of clinical-grade dendritic cell vaccine for acute myeloid leukemia.
    Tan YF; Sim GC; Habsah A; Leong CF; Cheong SK
    Malays J Pathol; 2008 Dec; 30(2):73-9. PubMed ID: 19291915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apoptosis of monocytes and the influence on yield of monocyte-derived dendritic cells.
    Bohnenkamp HR; Burchell JM; Taylor-Papadimitriou J; Noll T
    J Immunol Methods; 2004 Nov; 294(1-2):67-80. PubMed ID: 15604017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Closed system generation of dendritic cells from a single blood volume for clinical application in immunotherapy.
    Elias M; van Zanten J; Hospers GA; Setroikromo A; de Jong MA; de Leij LF; Mulder NH
    J Clin Apher; 2005 Dec; 20(4):197-207. PubMed ID: 15892082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficient induction of specific cytotoxic T lymphocytes to tumor rejection peptide using functional matured 2 day-cultured dendritic cells derived from human monocytes.
    Tanaka F; Yamaguchi H; Haraguchi N; Mashino K; Ohta M; Inoue H; Mori M
    Int J Oncol; 2006 Nov; 29(5):1263-8. PubMed ID: 17016660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical-grade manufacturing of autologous mature mRNA-electroporated dendritic cells and safety testing in acute myeloid leukemia patients in a phase I dose-escalation clinical trial.
    Van Driessche A; Van de Velde AL; Nijs G; Braeckman T; Stein B; De Vries JM; Berneman ZN; Van Tendeloo VF
    Cytotherapy; 2009; 11(5):653-68. PubMed ID: 19530029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IFN-gamma, as secreted during an alloresponse, induces differentiation of monocytes into tolerogenic dendritic cells, resulting in FoxP3+ regulatory T cell promotion.
    Eljaafari A; Li YP; Miossec P
    J Immunol; 2009 Sep; 183(5):2932-45. PubMed ID: 19696431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An improved protocol for generation of immuno-potent dendritic cells through direct electroporation of CD14+ monocytes.
    Milano F; van Baal JW; Rygiel AM; Bergman JJ; Van Deventer SJ; Kapsenberg ML; Peppelenbosch MP; Krishnadath KK
    J Immunol Methods; 2007 Apr; 321(1-2):94-106. PubMed ID: 17336322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dendritic cells: limited potential in immunotherapy.
    Soruri A; Zwirner J
    Int J Biochem Cell Biol; 2005 Feb; 37(2):241-5. PubMed ID: 15474968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatoma cells inhibit the differentiation and maturation of dendritic cells and increase the production of regulatory T cells.
    Li L; Li SP; Min J; Zheng L
    Immunol Lett; 2007 Nov; 114(1):38-45. PubMed ID: 17945351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of Influenza Matrix Protein 1 and MelanA-specific T lymphocytes in vitro using mRNA-electroporated dendritic cells.
    Tuyaerts S; Michiels A; Corthals J; Bonehill A; Heirman C; de Greef C; Noppe SM; Thielemans K
    Cancer Gene Ther; 2003 Sep; 10(9):696-706. PubMed ID: 12944989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effective clinical-scale production of dendritic cell vaccines by monocyte elutriation directly in medium, subsequent culture in bags and final antigen loading using peptides or RNA transfection.
    Erdmann M; Dörrie J; Schaft N; Strasser E; Hendelmeier M; Kämpgen E; Schuler G; Schuler-Thurner B
    J Immunother; 2007 Sep; 30(6):663-74. PubMed ID: 17667530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of alpha-Type-1 polarizing and standard dendritic cell cytokine cocktail for maturation of therapeutic monocyte-derived dendritic cell preparations from cancer patients.
    Trepiakas R; Pedersen AE; Met O; Hansen MH; Berntsen A; Svane IM
    Vaccine; 2008 Jun; 26(23):2824-32. PubMed ID: 18450338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electroporation of immature and mature dendritic cells: implications for dendritic cell-based vaccines.
    Michiels A; Tuyaerts S; Bonehill A; Corthals J; Breckpot K; Heirman C; Van Meirvenne S; Dullaers M; Allard S; Brasseur F; van der Bruggen P; Thielemans K
    Gene Ther; 2005 May; 12(9):772-82. PubMed ID: 15750615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cryopreservation of high concentrated PBMC for dendritic cell (DC)-based cancer immunotherapy.
    Heo YJ; Son CH; Chung JS; Park YS; Son JH
    Cryobiology; 2009 Apr; 58(2):203-9. PubMed ID: 19152796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel approach to induce human DCs from monocytes by triggering 4-1BBL reverse signaling.
    Ju S; Ju S; Ge Y; Qiu H; Lu B; Qiu Y; Fu J; Liu G; Wang Q; Hu Y; Shu Y; Zhang X
    Int Immunol; 2009 Oct; 21(10):1135-44. PubMed ID: 19684160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiation of monocyte-derived dendritic cells under the influence of platelets.
    Nguyen XD; Müller-Berghaus J; Kälsch T; Schadendorf D; Borggrefe M; Klüter H
    Cytotherapy; 2008; 10(7):720-9. PubMed ID: 18985478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.